Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Carvolix

Market Cap 227M 197M 181M 170M 317M 21.7B 324M 2.16B 837M 10.46B 851M 833M 36.37B P/E Ratio 2025 *
-7.5x
P/E Ratio 2026 * -7.24x
Enterprise Value 254M 221M 204M 191M 356M 24.36B 364M 2.43B 940M 11.74B 955M 935M 40.84B EV / Sales 2025
-
EV / Sales 2026 * 177x
Free-Float
21.57%
Yield 2025 *
-
Yield 2026 * -
1 day+2.71%
1 week+1.49%
Current month+3.33%
1 month+12.91%
3 months+5.57%
6 months+137.63%
Current year+97.11%
1 week 3.3
Extreme 3.3
3.6
1 month 3.02
Extreme 3.02
3.8
Current year 1.73
Extreme 1.73
5.22
1 year 1.16
Extreme 1.16
5.22
3 years 0.93
Extreme 0.93
5.22
5 years 0.93
Extreme 0.93
8.6
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap.
25-10-23
Truffle Capital SAS
BuyCompany 16,176 0.0411%
25-09-26
Truffle Capital SAS
BuyCompany 18,382 0.0467%
24-02-05
Truffle Capital SAS
BuyCompany 1,419,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
+2.71%+1.49%+139.30%+165.37% 227M
-0.32%-0.72%+25.66%-1.48% 12.52B
-4.84%-3.63%+51.96%+31.80% 6.32B
+3.77%+0.64%+4.18%-20.81% 5.38B
+5.17%+10.03% - - 4.34B
+2.70%+0.32%-28.98%+17.92% 4.16B
-0.51%-2.39%-31.01%-22.90% 3.73B
+6.37%-1.56%+2.02%-58.58% 2.05B
+0.18%-1.07%+35.70%+181.16% 1.65B
-2.11%-1.15%+56.79%-0.82% 1.59B
Average +1.32%+0.46%+28.40%+32.41% 4.2B
Weighted average by Cap. +0.68%+0.34%+16.50%+7.27%

Financials

2025 2026 *
Net sales - 1.62M 1.41M 1.3M 1.22M 2.27M 155M 2.32M 15.48M 5.99M 74.86M 6.09M 5.96M 260M
Net income -22.08M -19.16M -17.67M -16.55M -30.93M -2.11B -31.57M -211M -81.59M -1.02B -82.9M -81.12M -3.54B -33.75M -29.29M -26.99M -25.29M -47.26M -3.23B -48.24M -322M -125M -1.56B -127M -124M -5.42B
Net Debt 27.81M 24.13M 22.24M 20.84M 38.94M 2.66B 39.75M 265M 103M 1.28B 104M 102M 4.46B 60.81M 52.77M 48.64M 45.58M 85.15M 5.82B 86.93M 580M 225M 2.81B 228M 223M 9.76B
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
76
Date Price Change Volume
26-06-12 3.410 +2.71% 1,180
26-06-11 3.320 -4.05% 9,769
26-06-10 3.460 -3.08% 5,512
26-06-09 3.570 +1.13% 8,763
26-06-08 3.530 +5.06% 16,316
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.320EUR
Average target price
4.933EUR
Spread / Average Target
+48.59%

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!